Anzeige
Mehr »
Donnerstag, 28.05.2026 - Börsentäglich über 12.000 News
>>> Pacific startet 15.000m-Bohrprogramm <<<
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DZJ0 | ISIN: US44148G2049 | Ticker-Symbol:
NASDAQ
28.05.26 | 15:56
1,925 US-Dollar
+41,54 % +0,565
Branche
Halbleiter
Aktienmarkt
Sonstige
1-Jahres-Chart
ROCKET ONE INC Chart 1 Jahr
5-Tage-Chart
ROCKET ONE INC 5-Tage-Chart

Aktuelle News zur ROCKET ONE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14:29From biotech to orbit: Rocket One's AI and space re-brand sends shares flying2
14:25Rocket One Inc. - 8-K, Current Report1
14:19Rocket One Inc.: Rocket One Accepted into AMD AI Developer Program to Advance Simulation of Next-Generation Nanomagnetic AI Accelerator Architecture for AI, Defense and Space Applications132Access to AI Developer Cloud Resources is Expected to be Utilized to Support Modeling of Energy-Efficient Semiconductor Technologies for AI, Defense and Space Applications ...
► Artikel lesen
08:54Why Hoth Therapeutics (HOTH) Stock Is Surging After Hours Today8
MiHoth Therapeutics wird zu Rocket One: Aktie schießt nach Schwenk zur Raumfahrttechnologie in die Höhe9
MiStrategische Neuausrichtung: Hoth Therapeutics firmiert in Rocket One um2
MiHoth Therapeutics completes name change to Rocket One6
MiHoth Therapeutics, Inc.: Hoth Therapeutics Becomes Rocket One Inc. (Nasdaq: RKTO), Targeting the Space Economy with Next-Generation Nanomagnetic AI Chip Technology and Ultra-Low-Power, Radiation-Tolerant Computing for Space and Defense Applications254Company Adopts Space-Focused Identity, New Ticker "RKTO," and Exclusive License of AI Chip Architecture Designed for Ultra-Low-Power, Radiation-Tolerant Computing...
► Artikel lesen
ROCKET ONE Aktie jetzt für 0€ handeln
21.05.Hoth Therapeutics, Inc. - 8-K, Current Report2
19.05.Hoth Therapeutics to rebrand as Rocket One, enter AI chips2
19.05.Hoth Therapeutics, Inc.: AI Chip Energy Efficiency: Hoth Therapeutics Restructures as Rocket One Inc. to Enter the AI Semiconductor Infrastructure Market with Acquisition of Exclusive Rights to Next Generation AI Semiconductor Acceleration Technology260Company Targets Power Demands of AI Data Centers Through Patented Nanomagnetic Semiconductor and Spintronic Computing Technologies for AI, Defense, and Space Applications ...
► Artikel lesen
19.05.EXCLUSIVE: Hoth Therapeutics To Rebrand To Pursue AI Chip Technologies1
05.05.Hoth Therapeutics secures Spain approval for phase 2a trial13
05.05.Hoth Therapeutics, Inc.: Hoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer Patients88Regulatory Clearance in Spain Advances Randomized, Placebo-Controlled Study; Patients Show Meaningful Reductions in EGFR-Inhibitor Skin Toxicities with No Treatment...
► Artikel lesen
04.05.Hoth Therapeutics, Inc. - 8-K, Current Report-
17.04.Weekly Buzz: FDA Okays Travere Therapeutics, Royal Philips; Rejects Replimune; American Industrial Partners Snaps Up Avanos Medical; PDS Biotechnology, Hoth Therapeutics, Spyre Therapeutics, Paces Trials1.138INDIANAPOLIS (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S., Taiwan, and Europe, alongside FDA rejections, collaborations, acquisitions, and positive...
► Artikel lesen
16.04.Hoth Therapeutics, Inc. - 8-K, Current Report-
14.04.Hoth Therapeutics reports preclinical data on GDNF for fatty liver disease5
13.04.Hoth Therapeutics, Inc.: Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide156Statistically Significant Reduction in Srebf1 (Fat Production) and Increased Ppara (Fat Metabolism) Position GDNF as Next-Generation Therapy for MAFLD and Obesity ...
► Artikel lesen
02.04.Hoth Therapeutics schließt Direktplatzierung über 2 Millionen US-Dollar ab5
Weiter >>
70 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1